Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease

Journal of Immunology

Volumn 178, Issue 12, 2007, Pages 8212-8220

  Hart, Melanie ^a   Steel, Alan ^a   Clark, Sally A ^a   Moyle, Graeme ^b   Nelson, Mark ^b   Henderson, Don C ^b   Wilson, Robert ^c   Gotch, Frances ^a   Gazzard, Brian ^b   Kelleher, Peter ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b NATIONAL HEALTH SERVICE   (United Kingdom)

^c ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PNEUMOCOCCUS VACCINE; TETANUS TOXOID;

ADULT; ARTICLE; DRUG RESPONSE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; PRIORITY JOURNAL; RISK FACTOR; SPLENECTOMY; STREPTOCOCCUS INFECTION;

EID: 34250176946     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.12.8212     Document Type: Article

References (45)

1. Barry, P. M., N. Zetola, J. C. Keruly, R. D. Moore, K. A. Gebo, and G. M. Lucas. 2006. Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors 1990-2003. AIDS 20: 437-444.
2. Rodriguez-Barradas, M. C., D. M. Musher, C. Lahart, C. Lacke, J. Groover, D. Watson, R. Baughn, T. Cate, and G. Crofoot. 1992. Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23 valent pneumococcal vaccine. J. Infect. Dis. 165: 553-556.
3. Falco, V., Q. Jordano, M. J. Cruz, O. Len, E. Ribera, M. Campins, M. Crespo, I. Ocana, M. J. Rodrigo, and A. Pahissa. 2006. Serological response to pneumococcal vaccination in HAART-treated patients: one year follow up study. Vaccine 24: 2567-2574.
4. Rodriguez-Barradas, M. C., I. Alexandraki, T. Nazir, M. Foltzer, D. M. Musher, S. Brown, and J. Thornby. 1992. Response of human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy to vaccination with 23-valent pneumococcal polysaccharide vaccine. Clin. Infect. Dis. 37: 438-447.
5. Bernasconi, N. L., E. Traggiai, and A. Lanzavecchia. 2002. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298: 2199-2202.
6. Traggiai, E., R. Puzone, and A. Lanzavecchia. 2003. Antigen dependent and independent mechanisms that sustain serum antibody levels. Vaccine 21: S35-S37.
7. Moir, S., A. Malaspina, K. M. Ogwaro, E. T. Donoghue, C. W. Hallahan, L. A. Ehler, S. Y. Liu, J. Adelsberger, R. Lapointe, P. Hwu, et al. 2001. HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proc. Natl. Acad. Sci. USA 98: 10362-10367.
8. + T cell help in HIV-infected individuals. Proc. Natl. Acad. Sci. USA 100: 6507-6062.
9. Qiao, X. G., B. He, A. Chiu, D. M. Knowles, A. Chadburn, and A. Cerutti. 2006. Human immunodeficiency virus I Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nat. Immunol. 7: 302-310.
10. De Milito, A., C. Morch, A. S. Sonnerberg, and F. Chiodi. 2001. Loss of memory (CD27) B lymphocytes in HIV infection. AIDS 15: 957-964.
11. Nagase, H., K. Agematsu, K. Kitano, M. Takamoto, Y. Okubo, A. Komiyama, and K. Sugane. 2001. Mechanisms of hypergammaglobulinaemia by HIV infection: circulating memory B-cell reduction with plasmacytosis. Clin. Immunol. 100: 250-259.
12. + (memory) B cell reduction and characteristic B cell alteration in drug-naive and HAART-treated HIV-1 type 1-infected patients. AIDS Res. Hum. Retroviruses 20: 219-226.
13. De Milito, A., A. Nilsson, K. Titanji, R. Thorstensson, E. Reizenstein, M. Narita, S. Grutzmeier, A. Sonnerborg, and F. Chiodi. 2004. Mechanisms of hypergammaglobulinaemia and impaired antigen specific humoral immunity in HIV-1 infection. Blood 103: 2180-2186.
14. Titanji, K., A. De Milito, A. Cagigi, R. Thorstensson, S. Grutzmeier, A. Atlas, B. Hejdeman, F. P. Kroon, L. Lopalco, A. Nilsson, and F. Chiodi. 2006. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 108: 1580-1587.
15. Weller, S., C. A. Reynaud, and J. C. Weill. 2005. Vaccination against encapsulated bacteria in humans: paradoxes. Trends Immunol. 26: 85-89.
16. Carsetti, R., M. H. Rosado, and H. Wardemann. 2004. Peripheral development of B cells in mouse and man. Immunol. Rev. 197: 179-191.
17. + B cells are crucial in secondary immune responses by producing high affinity IgM. Clin. Immunol. 108: 128-137.
18. Weller, S., M. C. Braun, B. K. Tan, A. Rosenwald, C. Cordier, M. E. Conley, A. Plebani, D. S. Kumararatne, D. Bonnet, O. Tournihac, et al. 2004. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harbouring a prediversified immunoglobulin repertoire. Blood 104: 3647-3654.
19. Weller, S., C. A. Reynaud, and J. C. Weill. 2005. Splenic marginal zone B cells in humans: where do they mutate their Ig receptor. Eur. J. Immunol. 35: 2789-2792.
20. Sims, G. P., R. Ettinger, Y. Shirota, C. H. Yarbora, G. G. Illei, and P. E. Lipsky. 2005. Identification and characterization of circulating human transitional B cells. Blood 105: 4390-4398.
21. Cuss, A. K., D. T. Avery, J. L. Cannons, L. J. Yu, K. E. Nichols, P. J. Shaw, and S. G. Tangye. 2006. Expansion of functionally immature transitional B cells is associated with human-immunodeficiency states characterized by impaired humoral immunity. J. Immunol. 176: 1506-1516.
22. Malaspina, A., S. Moir, J. Ho, W. Wang, M. L. Howell, M. A. O'Shea, G. A. Roby, C. A. Rehm, J. M. Mican, T. W. Chun, and A. S. Fauci. 2006. Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7. Proc. Natl. Acad. Sci. USA 103: 2262-2267.
23. + T-cells predict functional responses to immunizations in chronic HIV infection. AIDS 17: 2015-2023.
24. Valdez, H., K. Y. Smith, A. Landay, E. Connick, D. R. Kuritzkes, H. Kessler, L. Fox, J. Spritzler, J. Roe, M. B. Lederman, et al. 2000. Response to immunisation with recall and neoantigen after prolonged administration of an HIV-1 protease inhibitor-containing regimen. AIDS 14: 11-21.
25. Conley, M. E., L. D. Notarangelo, and E. Etizoni. 1999. Diagnostic criteria for primary immunodeficiencies: representing (PAGID) Pan-American Group for Immunodeficiency and (ESID) European Society for Immunodeficiencies. Clin. Immunol. 93: 190-197.
26. -) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogenous disease. Blood 99: 1544-1551.
27. Piqueras, B., C. Lavenu-Bombled, L. Galicier, F. Bergeron-Van Der Cruyssen, L. Mouthon, S. Chevret, P. Debre, C. Schmitt, and E. Oksenhendler. 2003. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J. Clin. Immunol. 23: 385-400.
28. Lane, H. C., H. Masur, L. C. Edgar, G. Whalen, A. H. Rook, and A. S. Fauci. 1983. Abnormalities of B cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 309: 453-458.
29. Shirai, A., M. Cosentino, S. F. Leitman-Klinman, and D. Klinman. 1992. Human-immunodeficiency-virus infection induces both polyclonal and virus-specific-B cell activation. J. Clin. Invest. 89: 561-566.
30. Martinez-Mara, O., E. Crabb, R. T. Mitsuyasu, J. L. Fahey, and J. V. Giorgi. 1987. Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. J. Immunol. 138: 3720-3724.
31. Moir, S., A. Malaspina, O. K. Pickeral, E. T. Donoghue, J. Vasquez, N. J. Miller, S. R. Krishnan, M. A. Planta, K. F. Turney, J. S. Justement, et al. 2004. Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. J. Exp. Med. 200: 587-599.
32. Malaspina, A., S. Moir, S. M. Orsega, J. Vasquez, N. J. Miller, E. T. Donoghue, S. Kottilil, M. Gezmu, D. Follmann, G. M. Vodeiko, et al. 2005. Compromised B cell responses to influenza vaccination in HIV-infected individuals. J. Infect. Dis. 191: 1442-1450.
33. Kruetzmann, S., S. M. Rosado, H. Weber, U. Germing, O. Tournilhac, H. H. Peter, R. Berner, A. Peters, T. Boehm, A. Plebani, et al. 2003. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J. Exp. Med. 197: 939-945.
34. Shi, H. Y., T. Yamazaki, Y. Okubo, Y. Uehara, K. Sugane, and K. Agematsu. 2005. Regulation of aged humoral immune defence against pneumococcal bacteria by IgM memory B cell. J. Immunol. 175: 3262-3267.
35. Carsetti, R., M. M. Rosado, S. Donnanno, V. Guazzi, A. Soresina, M. Meini, A. Plebani, F. Aiuti, and I. Quinti. 2005. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J. Allergy Clin. Immunol. 115: 412-417.
36. Haynes, B. F., J. Fleming, E. W. St. Clair, H. Katinger, G. Stiegler, R. Kunert, J. Robinson, R. M. Scearce, K. Plonk, H. F. Staats, et al. 2005. Cardiolipin polyspecific autoreactivity in two broadly neutralising HIV-1 antibodies. Science 308: 1906-1908.
37. Masur, H., J. E. Kaplan, and K. K. Holmes. 2002. Guidelines for preventing opportunistic infections among HIV-infected persons: recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. Ann. Intern. Med. 137: 435-478.
38. Mackay, F., P. Schneider, P. Rennert, and J. Browning. 2003. BAFF and APRIL: a tutorial on B cell survival. Annu. Rev. Immunol. 21: 231-264.
39. Schneider, P. 2005. The role of APRIL and BAFF in lymphocyte activation. Curr. Opin. Immunol. 17: 282-289.
40. Allman, D., B. Srivastava, and R. C. Lindsley. 2004. Alternative routes to maturity: branch points and pathways for generating follicular and marginal zone B cells. Immunol. Rev. 197: 147-160.
41. He, B., X. G. Qiao, P. J. Klasse, A. Chiu, A. Chadburn, D. M. Knowles, J. P. Moore, and A. Cerutti. 2006. HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors. J. Immunol. 176: 3931-3941.
42. Rodriguez, B., H. Valdez, W. Freimuth, T. Butler, R. Asaad, and M. M. Lederman. Plasma levels of B-lymphocyte stimulator increase with HIV disease progression. AIDS 17: 1983-1985.
43. Salzer, U., and B. Grimbacher. 2005. TACltly changing tunes: farewell to a yin and yang of BAFF receptor and TACI in humoral immunity: new genetic defects in common variable immunodeficiency. Curr. Opin. Allergy Clin. Immunol. 5: 496-503.
44. Salzer, U., H. M. Chapel, A. D. B. Webster, Q. Pan-Hammarstrom, A. Schmitt-Graeff, M. Schleiser, H. H. Peter, J. K. Rockstroh, P. Schneider, A. A. Schaffer, et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat. Genet. 37: 820-828.
45. Castigli, E., S. A. Wilson, L. Garibyan, R. Rachid, F. Bonilla, L. Schneider, and R. Geha. 2005. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat. Genet. 37: 829-834.